Cuu Long Pharmaceutical JSC

Cuu Long Pharmaceutical JSC EBITDA per Employee

The EBITDA per Employee of Cuu Long Pharmaceutical JSC (DCL.VN) as of Nov 19, 2026 is 68.99 M VND. In the previous year, EBITDA per Employee was 80.40 M VND — a change of -14.19% (lower).

EBITDA per Employee

68.99 MVND

YoY

-14.19%

Last updated:

EBITDA per Employee of Cuu Long Pharmaceutical JSC is 2024 68.99 M VND. EBITDA per Employee of Cuu Long Pharmaceutical JSC was 2023 80.40 M VND. It decreases by -14.19% lower compared to the previous year.

The Cuu Long Pharmaceutical JSC EBITDA per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Employee
Date
EBITDA per Employee
Jan 1, 2014
65.69 M VND
Jan 1, 2015
95.88 M VND
Jan 1, 2016
118.34 M VND
Jan 1, 2017
98.48 M VND
Jan 1, 2018
20.60 M VND
Jan 1, 2023
80.40 M VND
Jan 1, 2024
68.99 M VND
The Cuu Long Pharmaceutical JSC EBITDA per Employee history
YEAREBITDA per EmployeeYoY
68.99 MVND-14.19%
80.40 MVND+290.20%
20.60 MVND-79.08%
98.48 MVND-16.78%
118.34 MVND+23.42%
95.88 MVND+45.97%
65.69 MVND—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cuu Long Pharmaceutical JSC Stock analysis

What does Cuu Long Pharmaceutical JSC do? Cuu Long Pharmaceutical JSC manufactures and sells pharmaceuticals, capsules, and medical instruments, including functional food, cosmetics, and chemicals for pharmaceutical production. The company imports and exports these products, and also produces specialized packaging for drugs and medical products. It cultivates traditional herbs as part of its operations. The firm targets domestic and international markets for its pharmaceutical and medical product lines, with a focus on manufacturing and distribution. Its products are sold to healthcare providers, pharmacies, and consumers through its own channels and partnerships. Cuu Long Pharmaceutical JSC's revenue streams include the sale of manufactured pharmaceuticals, capsules, medical instruments, functional food, cosmetics, and chemicals. The company also generates income from the export and import of these goods. Specialized packaging for drug and medical product manufacturers is another key revenue source. The cultivation of traditional herbs supports its production of herbal-based pharmaceuticals and supplements. The company serves healthcare providers, pharmacies, and consumers in domestic and international markets. Its product portfolio includes pharmaceutical drugs, capsules, medical equipment, functional food, cosmetics, and herbal products. The firm's manufacturing and distribution capabilities allow it to supply both B2B and B2C segments within the healthcare and wellness industry. Cuu Long Pharmaceutical JSC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cuu Long Pharmaceutical JSC stock

EBITDA per Employee of Cuu Long Pharmaceutical JSC is 68.99 M VND in 2024.

EBITDA per Employee of Cuu Long Pharmaceutical JSC changed from 80.40 M VND to 68.99 M VND, representing a -14.19% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Cuu Long Pharmaceutical JSC since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's VND is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Cuu Long Pharmaceutical JSC historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Cuu Long Pharmaceutical JSC

All Key Metrics — Cuu Long Pharmaceutical JSC